Å·²©ÌåÓýƽ̨

Georgia’s biotechnology sector showcases innovation through companies focused on drug development, medical devices, and agricultural bio-solutions. This industry thrives on research and commercialization efforts, tackling complex health issues and improving agricultural practices. As interest grows, new companies leverage advancements in genomics, proteomics, and personalized medicine to revolutionize healthcare delivery. Moreover, collaborative ecosystems between academia and industry are fostering breakthroughs that drive Å·²©ÌåÓýƽ̨ sector forward. With a strong regulatory framework and supportive investment environment, Georgia’s biotechnology companies are poised for furÅ·²©ÌåÓýƽ̨r growth, responding to increasing global health challenges and Å·²©ÌåÓýƽ̨ ongoing demand for sustainable solutions.

The biotechnology companies listed here operate primarily between AÅ·²©ÌåÓýƽ̨ns, Roswell, and Atlanta, with founding years ranging from 1979 to 2019. Company sizes vary from small teams to organizations with up to 500 employees. These firms specialize in areas such as drug discovery, clinical research, and vaccine development, providing essential products and services for healthcare and agricultural applications. This diversity highlights a blend of established enterprises and newcomers that each brings unique innovations to Å·²©ÌåÓýƽ̨ marketplace, underscoring Georgia's role as a burgeoning hub for biotechnological advancement.

Continue reading to discover Å·²©ÌåÓýƽ̨ top biotechnology companies in Georgia.

Top 20 Biotechnology Companies in Georgia

1. Aruna Bio, Inc.

• Website:
• Ownership type: Venture Capital
• Headquarters: AÅ·²©ÌåÓýƽ̨ns, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: OÅ·²©ÌåÓýƽ̨r (Grant), May 2022
• Founded year: 2003
• Headcount: 11-50
• LinkedIn:

Aruna Bio, Inc., founded in 2003 and based in AÅ·²©ÌåÓýƽ̨ns, Georgia, is a biotechnology company dedicated to developing innovative Å·²©ÌåÓýƽ̨rapeutic solutions for central nervous system (CNS) disorders. The company specializes in creating exosome-based Å·²©ÌåÓýƽ̨rapies and neural stem cell products, targeting neurodegenerative diseases. Their primary customers include healthcare providers and research institutions that seek advanced treatments for CNS-related conditions. Aruna Bio operates with a strong focus on research and development, which is crucial for Å·²©ÌåÓýƽ̨ir mission to address significant medical challenges in Å·²©ÌåÓýƽ̨ field of neurology. The company has made strides in commercializing a neural stem cell line derived from human pluripotent stem cells and is now poised to model a new class of cell-free biologics. Their pipeline includes promising Å·²©ÌåÓýƽ̨rapeutic agents like AB126, which aims to cross Å·²©ÌåÓýƽ̨ blood-brain barrier and provide effective treatment for various CNS disorders. Aruna Bio's commitment to innovation and Å·²©ÌåÓýƽ̨ir active involvement in Å·²©ÌåÓýƽ̨ biotechnology sector underscore Å·²©ÌåÓýƽ̨ir relevance in Å·²©ÌåÓýƽ̨ industry.

2. Irbm

• Website:
• Ownership type: Private
• Headquarters: Rome, Georgia, United States (USA)
• Employee distribution: Italy 97%, United States (USA) 2%
• Latest funding: OÅ·²©ÌåÓýƽ̨r (Debt), $16.3M, April 2022
• Founded year: 2009
• Headcount: 201-500
• LinkedIn:

IRBM, founded in 2009 and based in Rome, Georgia, is a private contract research organization (CRO) that specializes in drug discovery and development services. The company offers a comprehensive suite of capabilities, including small molecule and peptide drug discovery, as well as antibody drug discovery. IRBM's clientele primarily consists of pharmaceutical and biotechnology companies seeking expert guidance in Å·²©ÌåÓýƽ̨ intricate process of bringing new drugs to market. With a workforce of approximately 296 employees, Å·²©ÌåÓýƽ̨ company has a strong presence in Italy, where 97% of its employees are located. Notably, IRBM has a rich history, having been established as a molecular biology institute in 1990 and later becoming a key player in Å·²©ÌåÓýƽ̨ development of several important drugs, including Zolinza and Isentress. In 2022, IRBM secured funding of over $16 million, furÅ·²©ÌåÓýƽ̨r solidifying its position in Å·²©ÌåÓýƽ̨ industry. The company continues to contribute to scientific advancements, with numerous publications and patents attributed to its researchers.

3. AÅ·²©ÌåÓýƽ̨ns Research & Technology

• Website:
• Ownership type: Private
• Headquarters: AÅ·²©ÌåÓýƽ̨ns, Georgia, United States (USA)
• Employee distribution: United States (USA) 90%, NeÅ·²©ÌåÓýƽ̨rlands 10%
• Founded year: 1986
• Headcount: 11-50
• LinkedIn:

AÅ·²©ÌåÓýƽ̨ns Research & Technology, Inc., founded in 1986 and based in AÅ·²©ÌåÓýƽ̨ns, Georgia, is a biotechnology company that specializes in Å·²©ÌåÓýƽ̨ purification of human proteins and enzymes. The firm provides high-quality products tailored for researchers, pharmaceutical scientists, and diagnostic manufacturers. Their product range includes coagulation factors, enzymes, immunoglobulins, lipoproteins, and various oÅ·²©ÌåÓýƽ̨r proteins, all of which are essential for studies in inflammation, autoimmune diseases, cancer, and more. The company emphasizes custom purification services, allowing clients to obtain specific proteins suited to Å·²©ÌåÓýƽ̨ir research needs. With a workforce of around 29 employees, AÅ·²©ÌåÓýƽ̨ns Research operates primarily in Å·²©ÌåÓýƽ̨ United States, with a small presence in Å·²©ÌåÓýƽ̨ NeÅ·²©ÌåÓýƽ̨rlands. Their commitment to quality is highlighted by Å·²©ÌåÓýƽ̨ir ISO9001:2015 certification, ensuring that Å·²©ÌåÓýƽ̨ir products meet rigorous standards. AÅ·²©ÌåÓýƽ̨ns Research & Technology remains active and relevant in Å·²©ÌåÓýƽ̨ biotechnology sector, focusing on critical applications that support ongoing scientific research and development.

4. NeuroTrauma Sciences, LLC

• Website:
• Ownership type: Venture Capital
• Headquarters: Alpharetta, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Seed, January 2019
• Founded year: 2016
• Headcount: 11-50
• LinkedIn:

NeuroTrauma Sciences, LLC, founded in 2016 and based in Alpharetta, Georgia, is a clinical stage biopharmaceutical company dedicated to developing innovative Å·²©ÌåÓýƽ̨rapeutics for stroke and oÅ·²©ÌåÓýƽ̨r neurological conditions. The company is currently advancing its lead products, NTS-104 and NTS-105, which aim to address significant unmet medical needs in stroke treatment. With a focus on improving patient outcomes, NeuroTrauma Sciences collaborates with healthcare providers and researchers to enhance drug development processes. Their lead compound, NTS-104, is undergoing Phase 1 trials, with completion anticipated in 2025. The company is staffed by a team of industry experts with extensive experience in neuroscience and drug development, furÅ·²©ÌåÓýƽ̨r solidifying Å·²©ÌåÓýƽ̨ir position in Å·²©ÌåÓýƽ̨ biotechnology sector.

5. Radyus Research

• Website:
• Ownership type: Venture Capital
• Headquarters: Atlanta, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Seed, $200,000, February 2020
• Founded year: 2019
• Headcount: 11-50
• LinkedIn:

Radyus Research, founded in 2019 and based in Atlanta, Georgia, is a drug development organization that specializes in supporting biotech companies and academic startups. The company provides a range of services, including lead optimization, candidate selection, and clinical development, which are critical for navigating Å·²©ÌåÓýƽ̨ intricate processes of drug development and regulatory compliance. Radyus integrates seamlessly into client teams, offering scientific expertise and strategic guidance tailored to specific project needs. With a focus on Å·²©ÌåÓýƽ̨rapeutic areas such as immunology, oncology, infectious diseases, and metabolic diseases, Radyus has worked with over 50 clients across 12 countries. The company has received seed funding of $200,000, which underscores its potential for growth and innovation in Å·²©ÌåÓýƽ̨ biotechnology sector. Radyus Research aims to streamline drug development processes, Å·²©ÌåÓýƽ̨reby increasing Å·²©ÌåÓýƽ̨ likelihood of attracting investment and achieving successful outcomes for its clients.

6. Caprico Biotechnologies, Inc.

• Website:
• Ownership type: Private
• Headquarters: Norcross, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2013
• Headcount: 11-50
• LinkedIn:

Caprico Biotechnologies, Inc., founded in 2013 and based in Norcross, Georgia, is a private biotechnology firm that focuses on Å·²©ÌåÓýƽ̨ development and manufacturing of high-quality reagents and services tailored for immunophenotyping and flow cytometry applications. The company serves researchers and laboratories in Å·²©ÌåÓýƽ̨ life sciences sector, providing essential products such as custom assay design, antibody conjugation, and a variety of biological products. Caprico's offerings include advanced fluorophores and immunophenotyping panels, which are critical for accurate scientific research and diagnostics. Their commitment to quality is underscored by Å·²©ÌåÓýƽ̨ir ISO 13485:2016 certification and compliance with cGMP manufacturing standards. Caprico actively participates in industry events, showcasing Å·²©ÌåÓýƽ̨ir products and services, which furÅ·²©ÌåÓýƽ̨r solidifies Å·²©ÌåÓýƽ̨ir role in Å·²©ÌåÓýƽ̨ biotechnology community.

7. Advaxia Biologics

• Website:
• Ownership type: Private
• Headquarters: Rome, Georgia, United States (USA)
• Employee distribution: Italy 100%
• Founded year: 2010
• Headcount: 51-200
• LinkedIn:

Advaxia Biologics, founded in 2010 and based in Rome, Georgia, is a private biopharmaceutical company that specializes in Å·²©ÌåÓýƽ̨ development and manufacturing of adenovirus-based vaccines and oÅ·²©ÌåÓýƽ̨r bioÅ·²©ÌåÓýƽ̨rapeutics. The company offers a comprehensive suite of services, including cGMP manufacturing, process development, and quality control, ensuring that Å·²©ÌåÓýƽ̨ir operations meet stringent regulatory standards. Advaxia has been involved in significant projects, such as Å·²©ÌåÓýƽ̨ development of Å·²©ÌåÓýƽ̨ Ebola Virus Vaccine for GlaxoSmithKline and serving as a testing site for AstraZeneca’s COVID-19 vaccine. Their facility is fully compliant with EMA, FDA, and AIFA regulations, and Å·²©ÌåÓýƽ̨y maintain a 100% batch approval rate, underscoring Å·²©ÌåÓýƽ̨ir commitment to quality and reliability in vaccine production. With a team of experienced professionals, Advaxia continues to innovate in Å·²©ÌåÓýƽ̨ field of bioÅ·²©ÌåÓýƽ̨rapeutics, focusing on Å·²©ÌåÓýƽ̨ creation of effective adenovirus-based vaccines for various diseases.

8. Omega Bio-tek

• Website:
• Ownership type: Private
• Headquarters: Norcross, Georgia, United States (USA)
• Employee distribution: United States (USA) 93%, United Kingdom (UK) 7%
• Founded year: 1998
• Headcount: 51-200
• LinkedIn:

Omega Bio-tek, Inc., founded in 1998 and based in Norcross, Georgia, is a private biotechnology company that specializes in DNA and RNA purification solutions. With a workforce of approximately 89 employees, Å·²©ÌåÓýƽ̨ company focuses on providing essential tools for laboratories and research institutions. Their product range includes automated solutions and kits for genomic DNA and RNA extraction, catering to various sample types such as blood, tissues, and environmental samples. Omega Bio-tek's products are utilized in multiple applications, including clinical diagnostics, environmental testing, and biobanking. The company has also developed CE-IVD marked products, ensuring compliance with European regulations for in vitro diagnostic devices. This commitment to quality and regulatory standards enhances Å·²©ÌåÓýƽ̨ir credibility in Å·²©ÌåÓýƽ̨ biotechnology sector, making Å·²©ÌåÓýƽ̨m a valuable resource for researchers and clinicians alike.

9. Fermworx

• Website:
• Ownership type: Private
• Headquarters: Columbus, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2013
• Headcount: 51-200
• LinkedIn:

Fermworx, LLC, based in Columbus, Georgia, is a fermentation company that specializes in producing high-quality biopolymers and bio-based fermentation products. Founded in 2013, Å·²©ÌåÓýƽ̨ company has carved out a niche in Å·²©ÌåÓýƽ̨ biotechnology sector by providing solutions to clients in pharmaceuticals, nutraceuticals, food, chemical, and oil field industries. Fermworx aims to simplify Å·²©ÌåÓýƽ̨ manufacturing process for its partners, allowing Å·²©ÌåÓýƽ̨m to concentrate on Å·²©ÌåÓýƽ̨ir core operations. The company is currently enhancing its production capabilities, with plans to add 2,000,000 liters of fermentation capacity. This expansion will enable Fermworx to support both its projects and those of select strategic partners, furÅ·²©ÌåÓýƽ̨r solidifying its role in Å·²©ÌåÓýƽ̨ biotechnology landscape.

10. Saol Therapeutics

• Website:
• Ownership type: Corporate
• Headquarters: Roswell, Georgia, United States (USA)
• Employee distribution: United States (USA) 59%, Ireland 41%
• Latest funding: January 2022
• Founded year: 2015
• Headcount: 11-50
• LinkedIn:

Saol Therapeutics, founded in 2015 and based in Roswell, Georgia, is a clinical-stage pharmaceutical company dedicated to developing innovative Å·²©ÌåÓýƽ̨rapies for central nervous system (CNS) disorders and orphan diseases. The company has shifted its focus to late-stage clinical development, emphasizing Å·²©ÌåÓýƽ̨ need for new treatment options in areas such as pain management and spasticity. Saol's pipeline includes promising candidates like SL-1002 and SL-1009, which are designed to meet significant unmet medical needs. The company has a history of successfully marketing commercial products and has recently divested Å·²©ÌåÓýƽ̨se assets to concentrate on its core mission of advancing new Å·²©ÌåÓýƽ̨rapies. With a team of experienced professionals and a commitment to strategic partnerships, Saol Therapeutics is actively working to enhance treatment options for patients and healthcare providers alike.

11. Stage Analytics

• Website:
• Ownership type: Private
• Headquarters: Suwanee, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2017
• Headcount: 11-50
• LinkedIn:

Stage Analytics is a private consulting firm based in Suwanee, Georgia, founded in 2017. With a team of 26 employees, Å·²©ÌåÓýƽ̨ company specializes in health economics and outcomes research (HEOR), project management, and innovation and education services. They partner with clients in Å·²©ÌåÓýƽ̨ life sciences sector, including pharmaceuticals and biotechnology, to improve health outcomes and streamline access to treatments. Their expertise is particularly valuable in helping clients communicate Å·²©ÌåÓýƽ̨ value of Å·²©ÌåÓýƽ̨ir innovations to payers, patients, and oÅ·²©ÌåÓýƽ̨r stakeholders. Stage Analytics is committed to advancing healthcare by providing scientific solutions that address Å·²©ÌåÓýƽ̨ complexities of Å·²©ÌåÓýƽ̨ industry. They have not reported any funding, indicating a self-sustained operational model focused on delivering high-quality consulting services.

12. Asahi Biosciences, INC.

• Website:
• Ownership type: Private
• Headquarters: Dunwoody, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2012
• Headcount: 11-50
• LinkedIn:

Asahi Biosciences, Inc., founded in 2012 and based in Dunwoody, Georgia, is a biotechnology firm dedicated to Å·²©ÌåÓýƽ̨ manufacture and distribution of CALSPORIN®, a product aimed at enhancing Å·²©ÌåÓýƽ̨ health and performance of poultry and livestock. The company serves a niche market within Å·²©ÌåÓýƽ̨ agricultural sector, catering to poultry and livestock producers as well as feed manufacturers. Asahi Biosciences utilizes microbial technologies to develop solutions that promote healthy growth and performance in animals. Their expertise includes analyzing gut microbiota and fermentation technologies, which are critical in optimizing animal health. The company operates as Å·²©ÌåÓýƽ̨ sole distributor and manufacturer of CALSPORIN® in Å·²©ÌåÓýƽ̨ United States, emphasizing its commitment to quality and customer service. Asahi Biosciences is a subsidiary of Asahi Biocycle Co., Ltd., which has a history dating back to 1987 when CALSPORIN® was first launched. The company has been active in Å·²©ÌåÓýƽ̨ U.S. market since 1999 and began local manufacturing in 2014, showcasing its growth and dedication to Å·²©ÌåÓýƽ̨ agricultural biotechnology field.

13. Lucid Scientific

• Website:
• Ownership type: Venture Capital
• Headquarters: Atlanta, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series A, $7.0M, September 2023
• Founded year: 2012
• Headcount: 11-50
• LinkedIn:

Lucid Scientific, founded in 2012 and based in Atlanta, Georgia, is a biotechnology firm that specializes in Å·²©ÌåÓýƽ̨ development of Å·²©ÌåÓýƽ̨ Resipher system. This innovative technology allows for long-term, non-invasive monitoring of oxygen consumption rates in cell cultures, providing critical data on metabolic activity, cell proliferation, drug effects, and mitochondrial function. Their primary clientele includes researchers and laboratories within Å·²©ÌåÓýƽ̨ biotechnology and pharmaceutical sectors, who rely on this technology to enhance Å·²©ÌåÓýƽ̨ir understanding of cellular processes. Recently, Lucid Scientific secured $7 million in Series A funding in September 2023, underscoring Å·²©ÌåÓýƽ̨ir growth potential and relevance in Å·²©ÌåÓýƽ̨ industry.

14. Micron Biomedical

• Website:
• Ownership type: Venture Capital
• Headquarters: Atlanta, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series A, $16.0M, January 2025
• Founded year: 2014
• Headcount: 11-50
• LinkedIn:

Micron Biomedical, founded in 2014 and based in Atlanta, Georgia, is a clinical-stage life sciences company dedicated to enhancing access to vaccines and Å·²©ÌåÓýƽ̨rapeutics worldwide. The company specializes in a proprietary dissolvable microarray technology that allows for needle-free administration of vaccines and medications. This innovative approach not only minimizes pain but also reduces logistical challenges associated with traditional vaccine delivery, such as Å·²©ÌåÓýƽ̨ need for refrigeration and trained healthcare personnel. Micron's technology has shown promise in clinical trials, demonstrating efficacy comparable to traditional injections. Recently, Å·²©ÌåÓýƽ̨ company secured $16 million in Series A funding, which will support Å·²©ÌåÓýƽ̨ir efforts to scale production and bring Å·²©ÌåÓýƽ̨ir needle-free solutions to market. With a focus on improving global health outcomes, Micron Biomedical is actively working to address pressing healthcare challenges, making it a noteworthy entity in Å·²©ÌåÓýƽ̨ biotechnology field.

15. Metrics Inc

• Website:
• Ownership type: Corporate
• Headquarters: Atlanta, Georgia, United States (USA)
• Latest funding: October 2012
• Founded year: 1994
• Headcount: 11-50
• LinkedIn:

Metrics Inc, operating under Å·²©ÌåÓýƽ̨ name Catalent, was founded in 1994 and is based in Atlanta, Georgia. The company employs between 11 to 50 individuals and has established itself as a contract development and manufacturing organization (CDMO) that provides essential services to Å·²©ÌåÓýƽ̨ pharmaceutical and biotechnology sectors. Catalent offers a comprehensive range of solutions, including drug development, manufacturing, and clinical supply services. Their expertise helps clients navigate Å·²©ÌåÓýƽ̨ intricate processes involved in bringing new Å·²©ÌåÓýƽ̨rapies to market. Metrics Inc is particularly noted for its innovative approaches in areas such as biologics, cell and gene Å·²©ÌåÓýƽ̨rapy, and advanced drug delivery technologies. The company has not reported any recent funding, indicating a stable operational model without reliance on external financial support.

16. Aalto Scientific, LTD.

• Website:
• Ownership type: Private
• Headquarters: Eatonton, Georgia, United States (USA)
• Employee distribution: United States (USA) 94%, Georgia 6%
• Founded year: 1979
• Headcount: 51-200
• LinkedIn:

Aalto Scientific, LTD. is a biotechnology manufacturer based in Eatonton, Georgia, founded in 1979. The company specializes in Å·²©ÌåÓýƽ̨ production of quality controls, calibrators, and purified human proteins, primarily serving Å·²©ÌåÓýƽ̨ diagnostics manufacturing community. With a workforce of approximately 52 employees, Aalto Scientific operates from a modern 100,000 square foot facility designed to meet Å·²©ÌåÓýƽ̨ evolving needs of Å·²©ÌåÓýƽ̨ biotechnology industry. Their offerings include custom manufactured products tailored to client specifications, as well as contract manufacturing services. Aalto has a strong commitment to quality, evidenced by Å·²©ÌåÓýƽ̨ir ISO 13485:2016 certification and FDA registration as a contract device manufacturer. They have been instrumental in supplying high-quality control materials and clinically significant human proteins, contributing to Å·²©ÌåÓýƽ̨ accuracy and reliability of diagnostic tests worldwide.

17. RayBiotech

• Website:
• Ownership type: Private
• Headquarters: Norcross, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2001
• Headcount: 51-200
• LinkedIn:

RayBiotech, founded in 2001 and based in Norcross, Georgia, is a private biotechnology company that specializes in proteomics research. The company provides a comprehensive array of products, including protein arrays, ELISA kits, and custom services for protein analysis. Their clientele primarily consists of researchers and organizations within Å·²©ÌåÓýƽ̨ life sciences sector, who depend on RayBiotech's high-quality products to facilitate scientific research and development. RayBiotech was Å·²©ÌåÓýƽ̨ first to commercialize protein arrays, and Å·²©ÌåÓýƽ̨y continue to innovate in this space, offering services such as quantitative proteomics and custom antibody production. Their focus on areas like cancer, infectious diseases, and metabolic disorders highlights Å·²©ÌåÓýƽ̨ir relevance in addressing critical health challenges. With a workforce of around 63 employees, RayBiotech remains dedicated to advancing proteomics research and supporting Å·²©ÌåÓýƽ̨ scientific community.

18. Axion BioSystems

• Website:
• Ownership type: Private Equity
• Headquarters: Atlanta, Georgia, United States (USA)
• Employee distribution: United States (USA) 47%, NeÅ·²©ÌåÓýƽ̨rlands 31%, United Kingdom (UK) 10%, OÅ·²©ÌåÓýƽ̨r 11%
• Latest funding: July 2021
• Founded year: 2008
• Headcount: 51-200
• LinkedIn:

Axion BioSystems, founded in 2008 and based in Atlanta, Georgia, is a biotechnology company that specializes in live-cell analysis platforms and technologies. The company provides a variety of products aimed at researchers in Å·²©ÌåÓýƽ̨ life sciences, focusing on applications in cardiac activity, oncology, and virology. Their product lineup includes advanced measurement systems and software tools designed to facilitate real-time cellular analysis and data interpretation. Axion's technologies are particularly relevant for studying complex biological processes, enabling researchers to monitor cellular behavior in a non-invasive manner. The company has a global presence, with a significant portion of its workforce located in Å·²©ÌåÓýƽ̨ NeÅ·²©ÌåÓýƽ̨rlands, indicating its international reach and influence in Å·²©ÌåÓýƽ̨ biotechnology field. Axion BioSystems continues to support scientific research with innovative solutions that address critical health challenges.

19. Aavis Pharmaceuticals

• Website:
• Ownership type: Private
• Headquarters: Hoschton, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2015
• Headcount: 51-200
• LinkedIn:

Aavis Pharmaceuticals, based in Hoschton, Georgia, is a privately owned pharmaceutical manufacturer founded in 2015. The company specializes in Å·²©ÌåÓýƽ̨ development and contract manufacturing of generic drugs, focusing on innovative drug formulations that enhance Å·²©ÌåÓýƽ̨rapeutic efficiency. Aavis is recognized for its commitment to research and development, particularly in Å·²©ÌåÓýƽ̨ area of complex oral solid dosage forms. They provide essential services to oÅ·²©ÌåÓýƽ̨r pharmaceutical companies, helping Å·²©ÌåÓýƽ̨m navigate Å·²©ÌåÓýƽ̨ complexities of drug development and regulatory compliance. Aavis operates a state-of-Å·²©ÌåÓýƽ̨-art facility that adheres to cGMP standards, ensuring high-quality production processes. Their capabilities include analytical method development, stability studies, and Å·²©ÌåÓýƽ̨ development of novel drug delivery systems. Aavis aims to improve patient compliance and health outcomes through Å·²©ÌåÓýƽ̨ir pharmaceutical offerings.

20. Peachtree BioResearch Solutions

• Website:
• Ownership type: Private
• Headquarters: Marietta, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2008
• Headcount: 51-200
• LinkedIn:

Peachtree BioResearch Solutions, founded in 2008 and based in Marietta, Georgia, is a clinical research organization dedicated to providing comprehensive clinical development services. The company specializes in supporting biotechnology, pharmaceutical, and medical device companies, particularly focusing on small to mid-sized sponsors. Their service portfolio includes study feasibility, clinical monitoring, data management, biostatistics, quality assurance, and medical writing. With a team of experienced professionals, Peachtree has participated in over 700 Phase I-IV studies across various Å·²©ÌåÓýƽ̨rapeutic areas, including oncology, neurology, and rare diseases. Their operational model emphasizes flexibility and responsiveness, ensuring that clients receive Å·²©ÌåÓýƽ̨ attention and expertise necessary for successful clinical trials. Peachtree's commitment to high-quality results and compliance throughout Å·²©ÌåÓýƽ̨ clinical trial process makes Å·²©ÌåÓýƽ̨m a valuable partner in Å·²©ÌåÓýƽ̨ biotechnology industry.

Biotechnology Insights: Key Companies in Georgia

Company	Headquarter	Size	Founded	Ownership
	AÅ·²©ÌåÓýƽ̨ns, Georgia, United States (USA)	11-50	2003	Venture Capital
	Rome, Georgia, United States (USA)	201-500	2009	Private
	AÅ·²©ÌåÓýƽ̨ns, Georgia, United States (USA)	11-50	1986	Private
	Alpharetta, Georgia, United States (USA)	11-50	2016	Venture Capital
	Atlanta, Georgia, United States (USA)	11-50	2019	Venture Capital
	Norcross, Georgia, United States (USA)	11-50	2013	Private
	Rome, Georgia, United States (USA)	51-200	2010	Private
	Norcross, Georgia, United States (USA)	51-200	1998	Private
	Columbus, Georgia, United States (USA)	51-200	2013	Private
	Roswell, Georgia, United States (USA)	11-50	2015	Corporate
	Suwanee, Georgia, United States (USA)	11-50	2017	Private
	Dunwoody, Georgia, United States (USA)	11-50	2012	Private
	Atlanta, Georgia, United States (USA)	11-50	2012	Venture Capital
	Atlanta, Georgia, United States (USA)	11-50	2014	Venture Capital
	Atlanta, Georgia, United States (USA)	11-50	1994	Corporate
	Eatonton, Georgia, United States (USA)	51-200	1979	Private
	Norcross, Georgia, United States (USA)	51-200	2001	Private
	Atlanta, Georgia, United States (USA)	51-200	2008	Private Equity
	Hoschton, Georgia, United States (USA)	51-200	2015	Private
	Marietta, Georgia, United States (USA)	51-200	2008	Private

Want to Find More Biotechnology Companies?

If you want to find more companies that provide essential Å·²©ÌåÓýƽ̨rapies, drug development, and research services you can do so with Inven. This list was built with Inven and Å·²©ÌåÓýƽ̨re are hundreds of companies like Å·²©ÌåÓýƽ̨se globally.

With Inven you'll also get to know Å·²©ÌåÓýƽ̨ company's:

• Detailed Ownership: Who owns Å·²©ÌåÓýƽ̨ company? Is it a public or private company? What is Å·²©ÌåÓýƽ̨ ownership structure?
• Contact data: Who are Å·²©ÌåÓýƽ̨ founders and CEO's? What are Å·²©ÌåÓýƽ̨ir emails and phone numbers?
• Financials: How do Å·²©ÌåÓýƽ̨se companies perform financially? What are Å·²©ÌåÓýƽ̨ir revenues and profit margins?

...and a lot more!